ROIV - Roivant Sciences Ltd.

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Jun 30, 2026 10-Q ↗	Q4 FY2025 Mar 31, 2026 10-K ↗	Q3 FY2025 Dec 31, 2025 10-Q ↗	Q2 FY2025 Sep 30, 2025 10-Q ↗	Q1 FY2025 Jun 30, 2025 10-Q ↗	Q4 FY2024 Mar 31, 2025 10-K ↗	Q3 FY2024 Dec 31, 2024 10-Q ↗	Q2 FY2024 Sep 30, 2024 10-Q ↗	Q1 FY2024 Jun 30, 2024 10-Q ↗	Q4 FY2023 Mar 31, 2024 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Sep 30, 2023 10-Q ↗	Q1 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Mar 31, 2023 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Sep 30, 2022 10-Q ↗	Q1 FY2022 Jun 30, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Sep 30, 2021 10-Q ↗	Q1 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Mar 31, 2021 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Sep 30, 2020 10-Q ↗	Q1 FY2020 Jun 30, 2020 10-Q ↗
Revenue Growth YoY (%)	-33.5% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-519%)	-66.7% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-934%)	-77.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1073%)	-64.9% Weak → Weak Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-911%)	-96.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1301%)	-16.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-301%)	-75.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1046%)	-87.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1199%)	155.0% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1837%)	N/M	117.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1373%)	196.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2350%)	400.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4908%)	N/M	-29.9% Weak → Weak Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-474%)	-10.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-230%)	-44.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-652%)	-39.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-589%)	323.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3942%)	957.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11865%)	390.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4785%)	—	—	—	—
EPS Growth YoY (%)	21.2% Good Good Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	45.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-20.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-96.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	22.5% Good Good Year-over-year change in earnings per share Optimal: > 10%	N/M	-700.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	4.8% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	20.8% Good Good Year-over-year change in earnings per share Optimal: > 10%	92.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	15.0% Good Good Year-over-year change in net income	N/M	N/M	50.7% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-36.6% Weak → Weak Stable Year-over-year change in net income	-96.7% Weak ↑ Weak Improving Year-over-year change in net income	24.4% Good Good Year-over-year change in net income	N/M	-349.5% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-4.4% Weak ↓ Weak Declining Year-over-year change in net income	12.1% Fair ↑ Fair Improving Year-over-year change in net income	87.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-23.7% Weak ↑ Weak Improving Year-over-year change in net income	-39.9% Weak ↑ Weak Improving Year-over-year change in net income	-303.7% Weak ↓ Weak Declining Year-over-year change in net income	47.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-9.0% Weak ↑ Weak Improving Year-over-year change in net income	-489.0% Weak Weak Year-over-year change in net income	-2434.2% Weak Weak Year-over-year change in net income	—	—	—	—
FCF Growth YoY (%)	-22.7% Weak Weak Year-over-year change in free cash flow	—	—	—	-16.3% Weak Weak Year-over-year change in free cash flow	—	—	—	20.1% Good Good Year-over-year change in free cash flow	—	—	—	11.6% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-59.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	—	-51.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-50.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-20.5% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-6.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-28.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-31.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	92.4% Excellent → Excellent Stable Compound annual revenue growth over 3 years	-15.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	86.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	203.8% Excellent Excellent Compound annual revenue growth over 3 years	139.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-28.5% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-30.1% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-19.0% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	3.5% Caution Caution Compound annual revenue growth over 5 years	6.6% Fair Fair Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Jun 30, 2026 10-Q ↗	Q4 FY2025 Mar 31, 2026 10-K ↗	Q3 FY2025 Dec 31, 2025 10-Q ↗	Q2 FY2025 Sep 30, 2025 10-Q ↗	Q1 FY2025 Jun 30, 2025 10-Q ↗	Q4 FY2024 Mar 31, 2025 10-K ↗	Q3 FY2024 Dec 31, 2024 10-Q ↗	Q2 FY2024 Sep 30, 2024 10-Q ↗	Q1 FY2024 Jun 30, 2024 10-Q ↗	Q4 FY2023 Mar 31, 2024 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Sep 30, 2023 10-Q ↗	Q1 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Mar 31, 2023 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Sep 30, 2022 10-Q ↗	Q1 FY2022 Jun 30, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Sep 30, 2021 10-Q ↗	Q1 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Mar 31, 2021 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Sep 30, 2020 10-Q ↗	Q1 FY2020 Jun 30, 2020 10-Q ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	-218.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1553%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	1.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.7% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-8.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-4.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-24.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	10.9% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-5.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	18.0% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	5.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-3.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-18.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-205.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1815%)
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	-351.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.43x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-0.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.70x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	-2.03x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	5.38x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.75x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.22x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	2.81x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	34.37x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Jun 30, 2026 10-Q ↗	Q4 FY2025 Mar 31, 2026 10-K ↗	Q3 FY2025 Dec 31, 2025 10-Q ↗	Q2 FY2025 Sep 30, 2025 10-Q ↗	Q1 FY2025 Jun 30, 2025 10-Q ↗	Q4 FY2024 Mar 31, 2025 10-K ↗	Q3 FY2024 Dec 31, 2024 10-Q ↗	Q2 FY2024 Sep 30, 2024 10-Q ↗	Q1 FY2024 Jun 30, 2024 10-Q ↗	Q4 FY2023 Mar 31, 2024 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Sep 30, 2023 10-Q ↗	Q1 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Mar 31, 2023 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Sep 30, 2022 10-Q ↗	Q1 FY2022 Jun 30, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Sep 30, 2021 10-Q ↗	Q1 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Mar 31, 2021 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Sep 30, 2020 10-Q ↗	Q1 FY2020 Jun 30, 2020 10-Q ↗
Return on Invested Capital (%)	-8.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	7.2% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	77.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	—	-28.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-27.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-6.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	7.3% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	-6.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	69.2% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-13.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-17.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-20.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-4.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	6.7% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-55%)	-6.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-142%)	-2.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-117%)	-5.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-4.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-129%)	3.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-78%)	-4.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	1.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-88%)	—	83.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+458%)	-32.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-314%)	-32.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-314%)	—	-36.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-346%)	-25.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-267%)	-24.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-260%)	-16.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-209%)	-15.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-202%)	-10.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-168%)	-4.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	-28.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-289%)	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Jun 30, 2026 10-Q ↗	Q4 FY2025 Mar 31, 2026 10-K ↗	Q3 FY2025 Dec 31, 2025 10-Q ↗	Q2 FY2025 Sep 30, 2025 10-Q ↗	Q1 FY2025 Jun 30, 2025 10-Q ↗	Q4 FY2024 Mar 31, 2025 10-K ↗	Q3 FY2024 Dec 31, 2024 10-Q ↗	Q2 FY2024 Sep 30, 2024 10-Q ↗	Q1 FY2024 Jun 30, 2024 10-Q ↗	Q4 FY2023 Mar 31, 2024 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Sep 30, 2023 10-Q ↗	Q1 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Mar 31, 2023 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Sep 30, 2022 10-Q ↗	Q1 FY2022 Jun 30, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Sep 30, 2021 10-Q ↗	Q1 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Mar 31, 2021 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Sep 30, 2020 10-Q ↗	Q1 FY2020 Jun 30, 2020 10-Q ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	0.06x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-90%)	—	0.07x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-89%)	0.41x Good → Good Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-32%)	0.42x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-30%)	—	0.39x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-35%)	0.32x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-46%)	0.30x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-50%)	0.13x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-79%)	0.11x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-82%)	0.10x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-84%)	0.11x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-82%)	0.09x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-84%)	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	-8.97x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	535.88x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-29.90x Weak Weak Operating income divided by interest expense Optimal: > 5x	-31.02x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-108.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-180.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-163.91x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-441.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-61.44x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-803.62x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-351.52x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-257.47x Weak Weak Operating income divided by interest expense Optimal: > 5x	-144.69x Weak Weak Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$-1.25B	$-1.42B	$-1.48B	$-1.24B	$-1.24B	$-2.72B	$-1.99B	$-1.96B	$-5.37B	—	$-6.27B	$-1.02B	$-1.05B	—	$-1.15B	$-1.22B	$-1.53B	$-1.85B	$-2.01B	$-2.30B	$-1.81B	$-1.88B	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	-2.70x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	0.08x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.41x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.42x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.99x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.34x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.48x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.79x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.83x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.29x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.21x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.31x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Jun 30, 2026 10-Q ↗	Q4 FY2025 Mar 31, 2026 10-K ↗	Q3 FY2025 Dec 31, 2025 10-Q ↗	Q2 FY2025 Sep 30, 2025 10-Q ↗	Q1 FY2025 Jun 30, 2025 10-Q ↗	Q4 FY2024 Mar 31, 2025 10-K ↗	Q3 FY2024 Dec 31, 2024 10-Q ↗	Q2 FY2024 Sep 30, 2024 10-Q ↗	Q1 FY2024 Jun 30, 2024 10-Q ↗	Q4 FY2023 Mar 31, 2024 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Sep 30, 2023 10-Q ↗	Q1 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Mar 31, 2023 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Sep 30, 2022 10-Q ↗	Q1 FY2022 Jun 30, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Sep 30, 2021 10-Q ↗	Q1 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Mar 31, 2021 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Sep 30, 2020 10-Q ↗	Q1 FY2020 Jun 30, 2020 10-Q ↗
Revenue per Share (USD)	$0.00	—	$0.00	$0.00	$0.00	—	$0.01	$0.01	$0.07	—	$0.05	$0.05	$0.03	—	$0.02	$0.02	$0.01	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.26	$0.45	$-0.38	$-0.17	$-0.33	$-0.29	$0.23	$-0.31	$0.13	$-0.24	$6.37	$-0.40	$-0.38	$-0.03	$-0.49	$-0.42	$-0.48	$-0.39	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.38	—	$-0.29	$-0.28	$-0.31	—	—	—	$-0.26	—	—	—	$-0.33	—	—	—	$-0.37	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$5.86	$6.28	$6.02	$6.32	$6.37	$6.74	$7.21	$7.03	$7.35	—	$7.57	$1.18	$1.19	—	$1.31	$1.65	$1.97	$2.38	$2.70	$2.98	$7.74	$2.76	—	—	—
Tangible Book Value per Share (USD)	$5.86	$6.28	$6.02	$6.32	$6.37	$6.74	$7.21	$7.03	$7.17	—	$7.38	$1.01	$1.00	—	$1.11	$1.45	$1.77	$2.38	$2.70	$2.98	$7.74	$2.76	—	—	—
Basic Weighted Avg Shares (shares)	720.78M	—	696.86M	680.95M	680.29M	—	722.72M	735.47M	735.82M	—	800.59M	770.23M	759.27M	—	713.32M	699.89M	695.88M	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Jun 30, 2026 10-Q ↗	Q4 FY2025 Mar 31, 2026 10-K ↗	Q3 FY2025 Dec 31, 2025 10-Q ↗	Q2 FY2025 Sep 30, 2025 10-Q ↗	Q1 FY2025 Jun 30, 2025 10-Q ↗	Q4 FY2024 Mar 31, 2025 10-K ↗	Q3 FY2024 Dec 31, 2024 10-Q ↗	Q2 FY2024 Sep 30, 2024 10-Q ↗	Q1 FY2024 Jun 30, 2024 10-Q ↗	Q4 FY2023 Mar 31, 2024 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Sep 30, 2023 10-Q ↗	Q1 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Mar 31, 2023 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Sep 30, 2022 10-Q ↗	Q1 FY2022 Jun 30, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Sep 30, 2021 10-Q ↗	Q1 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Mar 31, 2021 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Sep 30, 2020 10-Q ↗	Q1 FY2020 Jun 30, 2020 10-Q ↗
Working Capital (USD)	$4.46B	$4.89B	$4.51B	$4.38B	$4.50B	$4.85B	$5.22B	$5.24B	$5.79B	—	$6.56B	$1.29B	$1.32B	—	$1.40B	$1.48B	$1.71B	$1.96B	$2.13B	$2.25B	$1.85B	$1.97B	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	$311.72M	—	$403.34M	$389.44M	$385.07M	—	$375.12M	$376.06M	$383.72M	$210.03M	$204.04M	$199.87M	$186.35M	$170.28M	—	—	—
Total Equity (USD)	$4.23B	$4.53B	$4.27B	$4.36B	$4.35B	$4.69B	$5.19B	$5.15B	$5.44B	—	$6.09B	$948.53M	$910.73M	—	$955.52M	$1.16B	$1.38B	$1.66B	$1.87B	$2.04B	$1.72B	$1.80B	—	—	—

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Jun 30, 2026 10-Q ↗	Q4 FY2025 Mar 31, 2026 10-K ↗	Q3 FY2025 Dec 31, 2025 10-Q ↗	Q2 FY2025 Sep 30, 2025 10-Q ↗	Q1 FY2025 Jun 30, 2025 10-Q ↗	Q4 FY2024 Mar 31, 2025 10-K ↗	Q3 FY2024 Dec 31, 2024 10-Q ↗	Q2 FY2024 Sep 30, 2024 10-Q ↗	Q1 FY2024 Jun 30, 2024 10-Q ↗	Q4 FY2023 Mar 31, 2024 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Sep 30, 2023 10-Q ↗	Q1 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Mar 31, 2023 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Sep 30, 2022 10-Q ↗	Q1 FY2022 Jun 30, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Sep 30, 2021 10-Q ↗	Q1 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Mar 31, 2021 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Sep 30, 2020 10-Q ↗	Q1 FY2020 Jun 30, 2020 10-Q ↗
Sales/Revenue/Turnover (USD)	$1.44M	$2.52M	$2.00M	$1.57M	$2.17M	$7.57M	$9.02M	$4.47M	$55.13M	$9.02M	$37.14M	$37.10M	$21.62M	$-2.37M	$17.05M	$12.53M	$4.32M	$9.22M	$24.34M	$13.99M	$7.74M	$15.15M	$5.75M	$1.32M	$1.58M
Depreciation Expense (USD)	$600.00K	$638.00K	$691.00K	$921.00K	$1.10M	$1.43M	—	—	$4.88M	$5.22M	—	—	$5.84M	$5.95M	—	—	—	$1.71M	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-189.84M	$302.99M	$-265.89M	$-113.52M	$-223.35M	$-206.47M	$169.38M	$-230.18M	$95.30M	$-151.12M	$5.10B	$-304.33M	$-291.82M	$-33.62M	$-352.01M	$-291.59M	$-331.81M	$-270.06M	$-284.54M	$-208.48M	$-82.18M	$-509.56M	$-261.03M	$-35.40M	$-3.24M
Operating Cash Flow (USD)	$-270.50M	$-163.82M	$-196.48M	$-185.66M	$-204.38M	$-172.56M	—	—	$-192.83M	$-108.46M	—	—	$-249.93M	$-179.09M	—	—	$-252.08M	$-147.47M	—	—	$-141.17M	$-106.07M	$-236.86M	$-98.05M	$-111.17M

Roivant Sciences Ltd.

Analytical Summary

25-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare ROIV with peers